The FDA-regulated products being recalled were stored in pallets at the Arlington, Texas, facility between May 1, 2022, and June 30, 2023, according to a recall summary by the FDA.
“The FDA Recalled Products were stored in this facility during a time when there may have been a pest control problem at the facility. In addition, because of recent unusually hot weather, the FDA Recalled Products may have been subjected to temperatures in excess of the storage condition instructions on the product labeling,” the recall said, adding there is a potential risk of salmonella contamination.
Inmar hadn’t received any adverse events reports related to the recall as of Aug. 23. The specific products affected were not listed, but included food and beverage products, medical devices and drugs.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
